Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
2675 studies found for:    "Kidney Failure"
Show Display Options
Rank Status Study
1 Recruiting NGAL Predictive Value of Acute Kidney Failure After Cardiac Surgery in Patients With Preoperative Chronic Kidney Failure
Conditions: Preoperative KIDNEY FAILURE, CHRONIC;   Postoperative KIDNEY FAILURE, ACUTE;   Cardiac Surgical Procedures
Intervention:
2 Unknown  Impact of Early Renal Involvement on the Development of Severe In-hospital Renal Failure
Conditions: Kidney Failure, Acute;   Renal Insufficiency, Acute;   Kidney Failure;   Renal Insufficiency
Intervention: Other: Early Renal Involvement
3 Terminated Safety Study of Renal Function in Patients With Chronic Kidney Failure Taking Lumiracoxib or Diclofenac for Arthralgia
Conditions: Kidney Failure, Chronic;   Arthralgia
Interventions: Drug: Lumiracoxib;   Drug: Diclofenac
4 Completed Pilot-Scale Clinical Trials of Kibow Biotics® in Chronic Kidney Failure
Condition: Chronic Kidney Failure
Intervention:
5 Unknown  Observational Study of Kibow Biotics in Chronic Kidney Failure Patients
Condition: Chronic Kidney Failure
Intervention: Dietary Supplement: Kibow Biotics/Renadyl
6 Completed Combined Bone Marrow and Kidney Transplant for Multiple Myeloma With Kidney Failure
Conditions: Kidney Failure, Chronic;   Multiple Myeloma
Intervention: Procedure: Combined bone marrow and kidney transplant
7 Completed Surveillance Study to Estimate the Incidence of Pure Red Blood Cell Aplasia Among Patients With Chronic Kidney Failure
Conditions: Pure Red-Cell Aplasia;   Chronic Kidney Failure
Intervention:
8 Completed Retrovir Capsules in the Treatment of HIV-Infected Patients in Renal Failure
Conditions: HIV Infections;   Kidney Failure, Chronic
Intervention: Drug: Zidovudine
9 Completed Darbepoetin Treatment of Anemia in Children With Chronic Renal Failure
Condition: Kidney Failure, Chronic
Intervention: Drug: darbepoetin alfa
10 Unknown  N-Acetylcysteine in Heart Failure With Coexistent Chronic Renal Failure
Conditions: Heart Failure, Congestive;   Kidney Failure, Chronic
Intervention: Drug: N-acetylcysteine
11 Completed An Investigation of N-acetylcysteine and Fenoldopam as Renal Protection Agents for Cardiac Surgery
Conditions: Kidney Failure, Acute;   Kidney Failure, Chronic;   Cardiac Surgical Procedures
Interventions: Drug: N-acetylcysteine;   Drug: fenoldopam
12 Completed Bosutinib In Subjects With Renal Impairment
Conditions: Renal Disease, End-Stage;   Renal Insufficiency, Chronic;   Renal Insufficiency, Acute
Intervention: Drug: Bosutinib
13 Unknown  Inspiratory Muscle Training in Patients With End Stage Renal Failure
Conditions: Renal Failure;   Chronic Renal Insufficiency
Interventions: Device: Inspiratory muscle training (URES HS730);   Device: Sham inspiratory muscle training (URES HS730)
14 Completed
Has Results
Risk of Nephrogenic Systemic Fibrosis (NSF) in Patients With Moderate Renal Insufficiency After the Administration of Magnevist
Conditions: Fibrosis;   Kidney Failure;   Renal Insufficiency
Intervention: Drug: Gadopentetate dimeglumine (Magnevist, BAY86-4882)
15 Completed Linezolid Pharmacokinetics In Patients With Impaired Renal Function (PPT6)
Conditions: Renal Failure;   Impaired Renal Function
Intervention: Drug: 600 mg linezolid
16 Unknown  Identification of Cardiovascular Risk Factors Linked to Renal Failure Progression
Condition: Chronic Renal Failure
Intervention:
17 Unknown  Safety and Efficacy of Autologous Bone Marrow Stem Cells for Treating Chronic Renal Failure
Condition: Chronic Renal Failure
Intervention: Other: Autologous bone marrow stem cells
18 Active, not recruiting PK and PD Study of IDN-6556 in Subjects With Severe Renal Impairment and Matched Healthy Volunteers
Conditions: Renal Impairment;   Renal Insufficiency;   Kidney Disease;   Kidney Diseases
Intervention: Drug: IDN-6556
19 Completed Two Schedules of Hepatitis B Vaccination in Predialysis Chronic Renal Failure Patients
Condition: Renal Failure
Interventions: Biological: four doses of Euvax B vaccine;   Biological: 20 μg (1 ml) three doses of Euvax B vaccine
20 Completed PK of Serelaxin in Severe Renal Impairment and ESRD
Conditions: Renal Failure, Chronic;   End-Stage Renal Disease
Intervention: Drug: Serelaxin

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years